---

Background and Objective: The reactive oxygen species (ROS) continuously are neutralized by antioxidant. Biological molecules become protected from oxidative stress under normal conditions. The production of ROS during hypoxia is reported In Vitro which is also known as reductive stress. In order to study this phenomenon at physiologic scales which occurs in routine activities, this study was conducted to evalute, the effect of voluntary apnea on serum ROS level. Materials and Methods: In this semi-experimental study, the participants were 12 healthy non-athlete men aged 21±3 years. At the end of normal depth inspiration the voluntary apnea had been started till 40 seconds. The respiratory rate and depth, heart rate and arterial oxyhemoglobine saturation percent were continuously monitored. Venous blood samples were collected at two times: (1) immediately after the apnea and (2) at the end of it and before re-breathing. The serum ROS level was measured using the standard D-ROM test. Results: The mean and the range of breath holding time were 52.5±7.9 and 40±61.7 seconds respectively. The heart rate and the arterial oxyhemoglobine saturation percent decrease 12.75% (P<0.003) and 2.05% (P<0.001) respectively. The mean and the range of basal vs. apnea of these parameters were as follow: 93.3±3.03 and 87-107 bpm vs. 81.43±3.7 and 71-93 bmp 97.6±.16 and 97-98 percent vs. 95.6±.33 and 94-97%. The serum ROS level after 40 seconds of apnea did not show significant differences. Conclusion: In non-athletes the voluntary apnea had no effect on serum reactive oxygen species level.

---

Background and Objective: Carbamazepine during pregnancy can induce various malformations. Recent studies have showed an increase in homocysteine level due to Carbamazepine administration. This study was to evaluate the effect of Carbamazepine on homocysteine serum level in pregnant mice and fetal malformations outcome. Materials and Methods: In this experimental study, 40 BALB/c timed-pregnant mice were allocated into 2 experimental and 2 control groups. The experimental groups were received daily intraperitoneal injections of 30 mg/kg (group I) or 60 mg/kg (group II) of Carbamazepine on gestational days 6 to 15. The control groups were received either - normal saline or Tween 20. Dams underwent Cesarean section on GD 18. External examinations were done and all data concerning malformations, weight and crown-rump of fetuses collected. Blood samples were collected from Dams' hearts prior to performing the Cesarean section. Homocysteine was measured using ELISA method. Data were analyzed using SPSS-18, ANOVA, Chi-Square and Tukey tests. Results: Significant increase in Homocysteine levels of dams’ serum compared to control groups was seen in both experimental groups I and II (10.56±1.31 and 11.11±1.64 µmol/L, respectively, P<0.05). The mean weight and crown-rump of the fetuses in both experimental groups were significantly reduced compared with those of the control groups (P<0.05). Various malformations such as limb defects, vertebral defects, facial deformity and severe malformations were observed in fetuses of both experimental groups. Conclusion: Serum elevation of homocysteine in Carbamazepine exposed pregnant mice may be a risk factor for induction of fetal malformations.

---

Background and Objective: Cardiovascular autonomic neuropathy (CAN) is the most common and important type of diabetic autonomic neuropathy. Silent myocardial infarction, respiratory failure and increased mortality are the outcomes of CAN. This study was carried out to screen the cardiovascular autonomic neuropathy in non- insulin dependent diabetics patients. Method: This descriptive - analytic study was carried on 70 (22 males, 48 females) non- insulin dependent diabetics’ patients. Resting heart rate, heart rate variability, orthostatic changes in heart rate, blood pressure and corrected QT interval were recorded for each subject. The final findings were categorized as follow: 0=normal, 1=borderline and 2=CAN positive. Results: 10 (14.3%) of patients were normal, 35 (50%) of patients were borderline and 25 (35.7%) of patients were considered cardiovascular autonomic neuropathy positive. There was significant differences between duration of diabetes and three CAN scores (P<0.05). The systolic blood pressure alterations showed the maximum correlation with CAN scores (r=0.509). Conclusion: In our study, the rate of cardiovascular autonomic neuropathy was higher than other reports. The most important risk factor for cardiovascular autonomic neuropathy was more than 10 years history of diabetes mellitus.